Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	41.2	4.8	4.0	12.2	5.0	0.1	19.0	5.5	5.3	16.2	7.9	8.1	1.2	13.2	1.1	5.3	10.2	7.8	15.6	4.4	5.6	9.5	2.7	13.6	1.9	10.8	8.1	7.3	9.8	6.3	2.2	31.7	8.5	7.9	2.7	1.4	3.2	3.7	7.4	2.6	3.7	12.1	8.0	4.1	4.7	0.8	8.1	1.0	7.3	7.3	1.1	22.5	9.0	6.4	0.0	1.2	13.9	0.0	0.6	0.1	1.3	0.2	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.0	8.8	2.6	0.0	0.0	0.5	0.0	23.6	0.0	0.5	0.0	0.3	0.1	0.0	0.0	7.5	1.1	0.0	0.0	2.4	0.1	27.1	0.3	0.1	128.3	0.0	0.0	0.0	40.5	0.0	0.7	5.4	0.8	0.4	0.0	0.8	0.0	0.0	0.0	0.5	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.0	5.5	5.3	4.4	5.6	10.8	8.1	8.5	8.0	8.1	6.4	166.3	3.2	4.8	84.2	0.0	17.5	87.2	0.0	4.6	0.0	6.9	15.9	6.6	2.8	2.6	38.6	2.1	1.0	0.2	1.1	0.0	69.7	0.9	13.2	179.1	221.0	1.2	0.0	4.2	3.3	0.6	31.4	1.5	33.8	0.0	8.4	27.1	0.3	7.5	0.0	14.3	1.1	0.0	0.3	20.1	0.4	2.5	2.7	26.6	21.5	0.0	0.2	0.0	26.7	0.6	45.5	1.0	2.2	0.0	115.7	0.0	10.8	0.1	0.1	0.0	20.7	94.8	0.3	0.7	1.3	13.5	1.6	3.2	12.1	0.9	36.7
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227726-57278105	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 28.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011138	Approved		Approved	"Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	No		10000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Plasma membrane"	"Actin filaments, Cytosol"	"HPA011138: AB_1844959"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	15.6	11.6	9.5	14.8	9.7	15.1	18.9	12.9	11.3	17.1	6.8	14.2	12.6	17.1	10.6	16.9	11.7	13.0	24.7	9.7	11.3	16.5	12.9	13.6	16.7	9.8	10.1	22.7	29.6	25.1	7.8	14.3	10.1	15.0	14.0	13.5	15.2	14.4	44.2	20.1	14.6	15.3	10.4	15.8	15.2	8.0	10.2	18.9	19.8	26.6	19.6	13.4	11.9	10.7	30.2	12.9	12.2	45.4	21.2	29.7	26.2	15.5	9.5	15.4	17.8	14.9	17.5	47.3	6.2	24.6	24.7	5.9	33.7	27.3	26.6	36.1	15.0	27.6	19.5	16.1	22.7	59.6	19.1	21.8	24.3	19.3	21.3	31.3	25.3	30.2	9.0	30.0	17.8	10.4	48.7	15.4	19.5	21.6	21.7	1.7	49.1	26.1	27.7	16.7	12.5	26.5	21.1	32.3	21.0	16.7	15.7	39.6	23.4	25.1	17.5	37.4	29.9	27.0	41.8	33.2	27.4	29.1	17.1	2.0	5.3	3.8	3.7	4.5	4.9	17.9	3.8	3.3	10.9	28.3	3.3	2.5	1.4	7.4	3.6	18.0	1.9	2.7	9.5	9.7	12.9	11.3	9.7	11.3	9.8	10.1	10.1	10.4	10.2	10.7	82.9	51.3	45.5	19.6	106.6	52.9	47.3	46.9	83.6	40.5	67.2	92.8	100.1	47.1	47.4	42.3	31.3	46.9	70.9	29.0	58.7	58.6	42.5	35.4	92.8	66.2	45.6	20.0	49.7	60.3	44.7	68.6	40.2	59.4	23.4	60.8	40.0	44.1	52.2	52.2	50.4	36.2	42.7	68.6	50.6	22.1	73.0	71.0	19.6	33.7	87.8	56.6	56.7	43.2	62.2	51.7	25.5	76.0	62.8	38.7	41.0	58.8	18.1	55.4	52.6	94.3	61.2	64.9	44.2	105.7	69.6	28.0	45.4	73.7	49.1	25.8
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.1;lymphoid tissue: 46.7"	"Cell type enriched"	"Detected in some"	11	"B-cells: 116.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.1	0.0	9.1	0.0	2.6	0.2	0.0	0.0	0.0	0.0	2.6	0.5	0.1	0.0	1.2	0.2	0.5	0.1	0.0	0.0	1.2	0.7	0.8	29.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.0	0.7	0.0	0.3	0.0	39.1	0.1	0.0	46.7	2.1	0.1	0.0	2.5	1.2	0.0	27.9	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	29.9	0.0	38.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.4	10.2	48.6	22.7	0.0	0.0	0.2	0.1	0.2	2.0	0.0	37.9	183.4	1.4	4.6	0.1	131.5	0.9	0.4	0.7	0.1	0.1	17.5	1.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	116.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.0
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.7;placenta: 29.6"	"Cell type enriched"	"Detected in many"	11	"Extravillous trophoblasts: 398.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 114.2;RT4: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		"Cluster 48: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	4.9	6.7	4.4	6.6	4.5	1.6	4.0	4.3	5.3	11.1	4.3	5.5	1.6	31.7	1.4	2.7	7.0	8.8	3.7	4.5	4.3	7.4	13.0	5.2	5.1	5.1	4.5	5.5	3.5	2.2	2.5	29.6	4.8	6.8	3.6	0.5	3.2	2.9	1.5	5.0	5.4	8.2	4.4	6.5	3.5	6.2	4.8	2.4	3.8	0.7	2.3	5.6	4.3	6.3	17.7	20.5	10.7	3.6	1.8	21.3	32.6	3.4	6.8	2.8	2.0	3.8	24.7	0.1	14.1	6.0	1.5	34.9	0.4	8.4	1.2	4.9	2.6	2.8	8.3	3.8	7.1	0.1	2.3	29.2	4.9	2.3	0.6	7.3	25.5	0.8	0.1	7.7	1.1	114.2	0.0	0.5	7.1	2.5	0.3	0.2	0.1	2.8	24.5	50.7	1.8	14.6	1.0	19.7	2.8	5.5	7.0	0.5	9.4	1.1	5.6	0.4	0.1	15.5	0.4	0.1	2.1	2.0	3.2	0.4	0.1	0.5	0.2	0.2	0.2	0.2	0.4	0.3	0.1	0.7	0.9	0.7	0.5	1.5	0.1	0.3	1.4	0.3	4.4	4.5	4.3	5.3	4.5	4.3	5.1	4.5	4.8	4.4	4.8	6.3	3.2	0.0	0.0	13.7	2.9	1.5	2.1	1.9	0.6	1.0	8.6	4.2	1.8	1.5	2.2	1.8	0.0	8.1	1.5	7.9	1.9	3.4	2.0	4.8	30.8	6.8	0.0	0.8	3.3	1.1	398.9	7.6	2.0	9.6	1.3	19.8	10.0	7.2	9.3	0.0	4.3	3.1	0.0	1.9	1.4	8.9	0.6	1.2	5.4	3.7	1.1	4.5	1.0	4.0	7.8	2.7	2.8	0.4	3.4	0.8	2.0	1.6	2.7	0.9	0.0	2.2	7.5	7.2	4.5	1.0	0.3	34.5	3.1	7.6	4.4	1.5
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586734-240617705	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: AB_2683037"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favorable (8.47e-5)"	"prognostic unfavorable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	10.0	18.6	16.8	6.8	16.2	7.9	9.6	21.0	25.0	11.8	16.5	12.7	13.1	10.7	3.7	14.5	13.7	6.1	24.6	17.9	14.0	23.8	14.7	12.2	10.6	15.6	15.8	13.3	12.6	5.3	18.1	4.5	15.4	14.9	7.1	10.6	10.2	5.3	5.8	12.1	14.0	2.8	12.6	29.8	15.8	17.0	16.7	6.4	13.2	2.8	5.4	11.1	10.0	16.8	8.0	11.2	11.2	9.5	4.5	3.6	19.7	9.9	4.1	6.5	5.9	8.7	18.7	5.9	3.5	3.6	8.9	12.7	3.0	6.6	3.3	23.0	19.8	10.9	20.4	16.0	7.1	7.1	15.3	2.6	4.8	6.7	2.7	6.7	5.2	16.8	12.5	7.3	2.8	7.1	16.2	27.5	17.4	9.5	8.1	15.5	8.1	13.1	9.9	9.8	28.1	22.0	6.3	9.3	13.8	3.5	4.8	9.3	8.6	11.0	9.7	9.5	11.8	16.3	4.2	10.7	10.4	12.8	11.0	1.5	0.9	1.8	1.0	0.6	0.3	1.0	0.6	1.1	0.4	1.1	0.7	0.9	4.1	3.0	0.6	1.2	1.3	0.4	16.8	16.2	21.0	25.0	17.9	14.0	15.6	15.8	15.4	12.6	16.7	16.8	8.9	3.2	6.0	19.6	7.5	4.6	7.2	3.8	6.2	14.9	6.2	5.3	9.5	12.8	4.8	9.2	14.6	5.4	14.2	7.2	7.9	13.0	1.9	14.7	5.7	7.0	11.3	1.7	9.5	9.1	5.2	5.3	4.6	13.8	22.9	11.3	7.5	3.0	6.7	48.8	9.0	6.3	8.2	5.3	1.7	2.6	9.0	7.8	1.8	7.5	7.7	13.4	8.2	7.5	7.2	13.8	4.6	9.4	7.4	10.1	9.9	6.2	9.4	18.6	0.0	5.6	7.6	12.6	7.7	3.7	5.3	5.5	11.3	9.0	6.4	6.9
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 133.2;Excitatory neurons: 159.5;Inhibitory neurons: 134.1;Microglial cells: 198.6;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	5.6	4.0	3.6	5.8	5.7	9.5	6.9	7.2	4.3	6.6	5.8	5.2	4.6	8.1	5.8	4.9	6.8	6.3	4.7	3.5	4.9	5.6	5.4	5.5	8.2	6.5	4.9	8.5	5.7	6.5	4.0	6.6	6.5	5.5	6.5	5.3	5.9	4.9	14.0	7.4	5.1	6.4	4.8	7.2	5.8	6.7	4.9	9.6	9.4	9.5	8.6	5.7	5.1	9.0	8.7	5.3	12.1	15.6	6.7	9.0	12.8	9.0	8.2	13.0	17.1	9.8	7.7	20.7	22.0	7.7	14.1	8.6	16.5	9.1	17.3	37.3	9.1	17.7	9.1	13.3	8.7	17.6	11.7	8.2	9.4	12.5	11.5	8.0	12.0	12.6	23.3	8.2	9.7	7.3	22.4	21.0	8.5	8.9	5.8	13.1	16.1	19.5	16.6	9.9	188.5	11.1	10.0	16.0	13.2	10.2	11.7	8.8	11.7	15.2	10.4	6.1	16.8	12.9	36.8	17.7	5.5	9.9	26.0	1.5	3.3	3.1	6.4	5.3	5.3	7.0	6.3	6.5	4.4	6.4	7.7	7.1	1.5	10.3	11.2	4.6	7.4	3.5	3.6	5.7	7.2	4.3	3.5	4.9	6.5	4.9	6.5	4.8	4.9	9.0	13.9	6.4	4.6	133.2	19.5	10.5	10.9	5.2	9.1	8.7	8.7	6.0	9.0	4.3	8.1	7.3	6.2	9.4	12.2	4.6	11.7	8.3	15.4	16.9	13.6	12.2	33.4	6.7	159.5	7.8	10.0	9.4	13.3	18.5	13.3	12.5	8.2	6.4	7.1	11.8	134.1	8.5	14.2	6.1	7.6	6.3	8.7	9.5	3.6	198.6	13.2	6.0	10.3	198.5	255.4	8.8	5.8	4.5	20.8	4.1	5.4	10.7	4.7	10.8	6.6	14.2	9.7	13.3	11.8	9.5	10.5	9.0	17.4	5.0	7.1	6.3
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.1	7.4	1.7	8.3	1.3	3.1	5.9	8.5	1.1	31.7	1.9	0.8	0.7	1.0	7.4	2.2	0.5	0.7	6.7	6.4	0.5	0.7	2.3	2.1	7.4	5.8	0.8	1.5	2.1	33.7	2.6	7.2	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	6.2	5.5	3.9	14.8	8.0	2.1	1.3	0.0	2.5	2.4	2.3	9.2	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.4	8.3	5.9	8.5	6.7	6.4	7.4	5.8	7.2	6.2	8.0	9.2	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009305	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 240.7;Pancreatic endocrine cells: 164.5;Proximal enterocytes: 139.0;Squamous epithelial cells: 142.0;Urothelial cells: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 3.3;intermediate monocyte: 3.3;non-classical monocyte: 9.0"	"Lineage enriched"	"Detected in single"	17	"monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.1;HaCaT: 35.0;HeLa: 33.9;hTERT-RPE1: 60.1;SiHa: 48.0;SK-MEL-30: 35.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	18.7	1.9	2.0	2.9	1.8	0.4	8.6	1.1	1.9	9.6	9.1	22.4	21.7	3.8	0.6	36.2	1.7	2.4	1.0	1.6	2.2	1.2	1.2	12.6	1.1	2.7	1.5	0.9	1.2	3.3	3.5	2.3	2.3	3.6	19.7	2.8	6.7	4.7	7.2	12.9	30.9	2.1	1.7	4.6	6.0	5.3	2.4	0.8	1.1	1.1	8.1	7.9	20.2	2.4	0.0	0.0	0.3	2.1	28.2	38.1	0.7	1.8	0.0	4.6	12.6	3.6	10.3	0.0	3.4	2.3	0.0	35.0	0.8	6.9	5.5	2.6	9.7	0.0	33.9	1.5	14.4	1.1	6.1	8.1	0.0	6.5	25.8	60.1	4.4	0.0	0.0	17.1	7.3	2.8	0.0	0.1	1.7	1.7	19.5	0.0	2.4	0.7	10.0	0.0	5.4	0.1	48.0	11.5	35.7	25.8	3.0	0.0	14.8	0.0	0.7	0.1	0.0	13.5	8.4	0.1	0.0	1.0	0.0	0.0	3.3	0.0	0.1	3.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.0	9.0	0.0	0.0	1.0	2.0	1.8	1.1	1.9	1.6	2.2	2.7	1.5	2.3	1.7	2.4	2.4	3.5	67.3	6.7	0.3	2.9	5.4	27.0	40.5	5.7	3.2	6.4	9.8	3.1	1.5	37.5	5.5	0.0	1.2	3.2	240.7	0.0	57.7	11.3	31.8	7.5	4.1	7.7	0.0	0.1	38.2	0.8	11.5	30.5	37.2	0.0	0.4	1.8	0.1	1.2	0.0	0.5	31.6	14.2	17.6	3.8	2.7	0.6	5.6	3.6	2.8	3.2	4.8	0.0	1.0	0.5	164.5	75.6	1.2	2.1	65.3	139.0	0.1	17.9	7.2	0.0	2.7	8.9	13.8	3.5	142.0	24.2	3.1	2.9	1.2	23.3	241.6
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"	P19835	9	133061981-133071861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	548	"pancreas: 110578.0"	"Group enriched"	"Detected in many"	10	"Breast glandular cells: 390.7;Exocrine glandular cells: 943.6"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA		110000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	10.0	3.0	3.1	2.2	3.2	0.9	10.4	4.8	4.5	6.4	13.5	2.9	21.6	3.2	200.8	7.1	11.1	0.4	22.0	4.1	2.7	7.5	6.4	2.1	4.1	2.9	2.8	57.2	110578.0	0.3	201.7	7.1	3.0	5.1	1.3	1.1	19.9	3.3	2.2	5.5	9.2	0.5	2.5	3.4	18.5	2.5	3.0	1.9	2.5	0.4	0.6	3.4	3.4	3.0	0.3	0.8	3.1	1.9	1.0	0.7	3.1	0.6	0.3	0.4	0.6	0.9	0.6	0.9	1.5	0.6	0.5	2.2	0.7	5.9	0.2	1.9	1.2	1.6	0.5	2.1	0.4	0.7	5.9	1.5	3.8	0.5	0.3	1.3	0.6	7.5	1.0	0.8	0.5	1.3	0.9	3.2	5.2	0.7	1.0	1.8	0.9	0.7	0.4	2.7	5.3	1.3	0.7	0.7	0.3	4.5	1.0	2.9	0.4	1.5	2.0	1.7	0.4	0.4	3.4	0.7	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.2	4.8	4.5	4.1	2.7	2.9	2.8	3.0	2.5	3.0	3.0	1.5	0.0	0.0	1.0	0.7	0.0	1.7	0.8	1.2	1.0	390.7	4.4	2.1	1.5	0.5	0.0	0.0	0.1	1.8	2.5	3.9	1.7	0.5	62.4	0.8	0.9	0.0	0.0	2.0	943.6	0.1	0.4	0.0	1.3	0.0	4.7	0.0	0.1	0.0	0.0	1.4	0.8	26.4	0.0	0.3	3.6	0.3	1.0	0.0	0.0	6.7	0.9	0.0	1.0	0.7	27.7	0.1	0.0	0.0	0.4	10.6	0.1	2.3	0.8	0.0	0.2	1.4	0.2	0.1	2.0	0.3	0.4	0.5	6.0	5.1	3.0
CISD2	"ERIS, Miner1, NAF-1, WFS2, ZCD2"	ENSG00000145354	"CDGSH iron sulfur domain 2"	Q8N5K1	4	102868974-102892807	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Autophagy		"Deafness, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015914	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA015914: AB_1846794"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.48e-3)"	"unprognostic (9.12e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	11.2	19.1	2.4	5.5	2.7	6.0	9.0	3.9	3.2	9.5	4.1	11.5	1.7	9.5	5.3	12.5	8.8	4.3	10.5	2.6	3.2	17.9	46.0	10.7	5.5	2.9	2.9	8.9	20.0	5.4	12.8	3.1	3.0	9.5	3.8	6.1	12.0	1.9	7.4	9.7	10.9	3.0	2.7	14.7	11.4	6.5	3.0	4.0	13.6	1.7	3.5	9.8	10.1	4.0	16.8	5.5	5.8	7.2	14.2	15.2	3.7	12.6	4.6	5.4	8.2	6.5	27.7	12.1	10.9	12.2	12.9	8.1	28.2	10.1	24.8	10.7	4.2	10.5	3.6	6.7	10.1	18.7	16.1	5.9	15.1	23.0	17.8	5.2	9.8	6.7	22.7	21.3	14.7	4.6	16.5	5.4	11.2	5.7	4.0	6.7	5.9	22.2	13.6	5.3	13.4	7.8	7.5	12.8	12.8	6.6	8.5	4.0	4.4	15.8	17.8	21.3	7.8	16.3	23.5	24.2	11.2	5.7	12.6	4.6	2.8	5.8	2.6	2.7	2.7	2.5	2.6	2.7	2.7	2.1	1.7	2.2	2.0	4.4	3.1	3.5	3.5	2.3	2.4	2.7	3.9	3.2	2.6	3.2	2.9	2.9	3.0	2.7	3.0	4.0	24.2	25.6	26.1	10.1	65.3	85.7	45.3	131.0	60.3	33.5	61.2	51.3	27.8	58.6	70.4	77.3	20.9	74.2	52.7	52.9	72.4	101.8	12.2	39.9	41.8	35.8	43.0	256.8	17.5	77.2	131.0	39.6	39.8	48.3	57.8	24.2	26.0	159.9	110.9	30.3	22.1	94.2	146.5	93.5	128.9	6.9	23.9	66.4	69.4	12.2	78.4	36.9	45.3	17.6	25.9	74.3	88.5	33.8	194.3	63.7	82.7	203.9	63.1	33.1	32.9	22.1	41.6	41.7	36.7	56.4	90.1	56.8	54.0	33.4	68.6	53.9
CLEC16A	"Gop-1, KIAA0350"	ENSG00000038532	"C-type lectin domain containing 16A"	Q2KHT3	16	10944564-11182186	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.9;Early spermatids: 118.7;Excitatory neurons: 93.3;Inhibitory neurons: 135.1;Late spermatids: 84.8;Oligodendrocyte precursor cells: 69.4;Oligodendrocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035814, HPA035815, HPA061385"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: AB_2684498"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.54e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.49e-1)"	"prognostic favorable (2.92e-6)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.03e-1)"	10.2	12.8	12.1	7.2	13.4	13.2	9.4	16.7	17.3	11.2	23.6	9.5	8.2	9.0	6.9	13.9	9.4	4.8	14.6	11.3	11.1	16.6	16.2	12.8	9.3	13.8	14.5	8.2	8.9	11.7	17.3	7.0	13.8	11.3	5.9	11.5	9.1	5.7	17.5	14.2	10.8	6.2	9.7	12.4	10.4	46.8	21.0	10.9	13.3	8.3	8.8	9.1	10.4	11.7	11.6	12.1	9.0	11.9	14.8	10.3	8.0	11.7	11.4	9.6	12.5	13.5	21.1	22.8	26.6	14.3	10.6	10.1	11.6	21.7	12.3	110.3	12.5	10.4	16.4	14.4	10.4	11.5	21.5	12.3	10.4	15.9	13.4	8.8	13.3	12.4	17.6	13.8	11.5	19.0	18.2	9.1	7.2	10.0	9.5	24.6	7.6	13.5	20.1	8.4	11.5	15.3	16.8	17.1	9.1	10.4	12.1	17.7	14.2	12.4	16.1	18.3	10.4	9.7	9.2	18.7	15.5	16.4	13.1	2.7	1.9	1.4	2.2	1.5	1.3	1.7	1.8	1.5	1.5	2.8	2.1	1.8	2.6	1.8	3.0	2.0	1.4	1.1	12.1	13.4	16.7	17.3	11.3	11.1	13.8	14.5	13.8	9.7	21.0	11.7	7.1	16.0	10.0	130.9	12.8	7.1	3.7	5.9	11.4	11.7	5.2	5.1	5.9	8.6	8.8	3.7	37.5	3.4	5.5	12.1	0.0	6.0	118.7	7.5	6.0	6.1	7.7	8.6	93.3	6.4	2.6	6.2	9.2	8.0	8.2	5.7	9.7	12.6	4.8	11.8	135.1	7.9	6.1	5.4	6.2	84.8	5.6	6.8	3.6	40.3	8.6	3.9	4.1	69.4	72.9	6.5	4.0	8.6	8.8	3.5	10.3	3.5	8.9	18.3	0.0	7.4	4.5	27.1	8.4	13.4	8.2	3.8	8.6	3.3	6.7	4.9
CTLA4	"CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203867771-203873965	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 37.4"	"Cell type enriched"	"Detected in some"	8	"T-cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	7	"T-reg: 44.5"	"Lineage enriched"	"Detected in single"	445	"T-cells: 44.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.5;SK-MEL-30: 3.0;U-266/70: 4.3;U-266/84: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.92e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.47e-3)"	"unprognostic (9.89e-6)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (9.86e-10)"	"unprognostic (4.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-2)"	1.1	0.2	0.4	18.5	0.4	6.1	1.0	0.4	0.7	0.6	0.5	1.3	0.3	0.3	0.0	1.6	0.6	5.2	0.5	0.5	0.5	0.6	0.7	2.9	37.4	1.3	0.7	0.1	0.4	0.5	0.3	0.3	1.1	1.5	3.2	0.0	0.5	1.0	0.1	0.7	6.2	0.8	0.6	3.9	2.9	1.1	0.5	10.1	1.1	0.2	17.0	5.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	4.3	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	6.2	0.8	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	44.5	0.6	0.4	0.4	0.4	0.7	0.5	0.5	1.3	0.7	1.1	0.6	0.5	0.5	0.4	0.0	3.2	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	4.1	0.0	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	3.3	0.0	2.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	1.0	0.2	0.9	0.1	41.9	0.0	0.0	0.1
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 15.2;thyroid gland: 5.7"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 22.1;monocytes: 22.8;Proximal tubular cells: 36.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 13.6;RH-30: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.67e-3)"	0.3	0.9	0.3	0.7	0.3	0.8	0.8	0.3	0.4	0.2	0.3	0.4	0.4	0.2	0.6	0.4	0.2	0.5	0.1	0.3	0.3	15.2	0.6	0.5	0.9	0.3	0.3	0.2	1.6	1.0	0.4	0.3	0.3	0.3	0.6	3.3	0.5	0.2	0.1	0.6	0.5	0.1	0.3	0.2	0.5	0.4	0.3	0.2	5.7	0.0	0.7	2.2	0.2	0.5	2.8	0.4	0.0	0.3	0.2	0.4	1.1	0.1	3.1	1.0	0.3	3.7	1.0	2.0	0.1	0.4	0.3	3.3	0.5	5.9	3.1	0.6	0.4	0.9	0.0	1.0	0.3	1.2	2.5	0.5	1.9	0.8	13.6	1.2	0.4	2.6	1.3	1.2	0.4	0.4	0.4	1.1	1.3	2.8	2.3	0.8	22.6	1.7	0.5	0.3	0.7	0.8	2.0	0.4	0.1	0.1	1.7	2.3	0.2	0.2	1.6	1.1	0.4	1.4	1.2	0.4	1.2	2.6	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.0	0.0	0.7	3.0	5.2	1.3	1.1	0.6	0.7	5.1	2.7	0.7	2.8	1.9	0.0	2.1	0.1	0.0	0.6	1.9	2.0	0.9	1.1	0.5	0.5	0.0	0.0	0.3	22.1	0.4	0.6	0.0	1.7	4.5	0.4	0.4	0.3	2.3	0.0	0.2	0.6	0.0	0.3	0.8	0.0	0.0	1.5	0.0	0.0	22.8	0.6	0.0	0.0	0.1	5.4	0.1	0.4	1.7	1.4	0.5	36.9	0.6	5.2	0.0	1.5	1.1	0.3	0.7	1.3	2.7	0.1	0.5	0.4	0.9	0.6
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627464	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.6"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.8;U-266/70: 44.0;U-698: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	3.3	3.1	0.8	4.0	1.1	2.6	1.6	1.6	1.4	2.3	1.6	4.7	6.2	1.9	1.0	1.6	1.3	1.4	1.5	0.8	1.5	2.0	1.9	1.8	3.2	1.0	1.2	1.9	19.6	3.4	1.1	3.2	0.9	4.0	1.8	0.1	9.7	1.2	2.0	1.4	5.0	0.9	1.5	3.1	12.3	1.0	1.2	1.3	3.5	0.0	2.3	1.9	1.8	2.1	8.7	3.3	1.2	4.3	2.8	2.0	15.9	12.4	1.1	0.7	2.1	3.5	2.9	46.8	8.0	1.3	3.1	7.2	1.6	1.3	1.1	25.3	7.1	4.6	1.7	2.0	1.1	3.9	12.3	0.1	1.5	0.7	2.0	0.8	1.4	4.9	3.0	8.7	0.6	4.4	5.5	2.2	6.2	2.7	7.2	25.1	7.0	8.2	1.3	5.0	5.6	9.9	6.3	6.5	8.2	1.7	2.2	4.4	3.9	2.5	5.5	10.8	7.1	44.0	24.4	31.0	4.6	4.2	6.2	0.0	0.1	0.1	0.3	0.0	0.2	1.0	0.2	0.8	0.1	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	1.1	1.6	1.4	0.8	1.5	1.0	1.2	0.9	1.5	1.2	2.1	9.2	9.6	7.5	14.7	43.8	20.3	8.9	7.2	26.7	8.4	14.7	8.9	8.2	17.2	7.2	12.9	8.4	4.1	13.4	14.0	0.0	3.7	0.1	18.4	18.3	7.6	13.7	1.7	31.3	6.5	6.9	15.2	40.2	39.2	1.3	4.4	8.9	11.8	4.6	1.7	39.0	30.1	14.2	5.1	41.2	0.7	7.5	27.7	32.0	21.5	3.9	3.0	9.2	20.1	26.2	7.0	7.7	5.7	121.3	13.0	5.4	2.9	7.7	2.3	0.0	13.4	9.4	3.1	3.6	23.8	18.3	6.7	12.8	3.5	6.8	16.6
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		4400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	8.4	3.1	0.4	1.4	0.5	0.1	7.1	0.7	0.4	7.1	0.4	2.3	1.8	22.1	7.4	2.3	6.9	1.2	1.6	0.4	0.7	4.2	31.9	0.8	1.4	1.2	1.4	8.3	28.5	27.8	10.9	44.0	0.9	3.4	2.0	0.5	4.2	5.8	2.7	1.7	1.3	10.2	0.8	1.9	1.7	1.6	1.0	2.2	20.1	3.2	0.8	2.7	4.9	0.8	0.0	1.3	1.2	0.1	34.1	5.3	0.0	9.2	9.4	3.5	9.5	4.1	1.1	0.0	0.8	5.9	7.2	0.0	1.3	0.2	14.8	0.3	1.8	0.0	1.1	12.0	1.0	0.0	4.2	8.8	0.4	9.6	0.4	4.1	4.3	0.7	0.0	1.8	21.1	2.6	0.0	0.0	7.9	1.6	1.3	0.0	10.2	0.3	0.2	0.4	3.4	0.0	0.2	1.3	4.2	5.7	3.9	0.0	2.9	27.6	1.0	1.9	9.1	3.4	0.0	0.0	12.6	0.0	3.5	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	0.0	0.4	0.5	0.7	0.4	0.4	0.7	1.2	1.4	0.9	0.8	1.0	0.8	2.6	0.0	1.7	0.3	1.5	1.5	9.9	0.0	0.6	4.5	28.7	19.9	6.4	5.7	0.1	1.8	0.0	3.0	1.2	16.7	5.9	0.3	4.8	3.9	80.2	4.1	0.0	8.0	3.5	10.6	2.1	56.9	6.1	3.2	0.0	9.4	3.3	111.6	4.6	1.7	10.5	12.7	0.0	2.9	5.9	6.7	25.1	3.9	1.8	12.2	0.2	3.6	0.0	21.6	1.6	5.2	3.9	70.0	0.4	2.3	6.7	25.2	0.1	0.5	13.1	12.6	18.8	4.1	2.2	0.1	1.3	6.2	2.6	1.9	2.5	1.7
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 254.3;Oligodendrocytes: 187.0;Paneth cells: 184.6;Proximal enterocytes: 240.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.4;neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 116.4;OE19: 119.1;RT4: 89.7;SK-BR-3: 106.5;SK-MEL-30: 149.5;T-47d: 122.2;WM-115: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025331, HPA045396, HPA070524"	Approved		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312, HPA070524: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	2.4	2.6	34.4	8.0	69.2	0.9	56.5	45.9	62.0	20.9	10.9	62.9	88.5	5.5	12.3	82.0	12.1	30.6	9.0	39.2	43.1	36.2	98.6	29.3	0.6	59.4	54.4	1.6	57.0	23.8	2.4	13.0	54.7	37.8	64.1	1.3	83.0	18.2	2.4	75.7	82.5	3.8	36.2	0.6	74.7	2.3	55.9	1.0	9.4	1.7	12.5	21.8	44.2	104.9	39.8	2.1	3.2	1.4	0.2	0.1	63.2	3.9	7.2	4.5	4.1	20.4	70.4	0.2	0.8	1.0	0.6	32.2	5.0	7.7	2.3	0.7	3.0	0.1	1.1	116.4	0.1	0.1	0.5	1.3	9.3	0.7	0.3	0.7	0.1	0.8	2.6	1.0	0.4	71.6	0.4	1.3	10.4	119.1	1.9	0.4	7.4	2.1	7.9	89.7	3.3	1.3	2.6	106.5	149.5	9.1	122.2	0.7	0.3	0.5	4.0	1.9	0.5	0.9	0.6	0.6	0.4	0.3	153.4	2.4	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	1.0	0.4	0.2	0.2	0.3	0.1	34.4	69.2	45.9	62.0	39.2	43.1	59.4	54.4	54.7	36.2	55.9	104.9	0.8	118.6	81.0	1.0	1.5	18.2	15.3	21.6	19.4	1.5	106.4	47.8	1.9	171.6	74.6	35.0	2.1	52.6	2.0	254.3	1.9	60.1	1.3	36.1	10.9	2.7	93.1	2.7	0.7	88.1	84.6	4.5	96.4	95.9	1.3	0.7	5.0	112.0	6.1	0.0	2.0	145.2	40.7	1.9	3.7	0.5	1.5	1.5	55.2	1.0	1.7	7.7	0.0	49.8	187.0	94.8	184.6	0.0	0.3	103.3	240.2	30.0	54.8	1.1	6.6	4.5	3.4	9.5	13.4	87.7	36.9	100.6	2.5	0.1	136.9	135.4
FOXP3	"AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID"	ENSG00000049768	"Forkhead box P3"	Q9BZS1	X	49250438-49270477	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.2;lymphoid tissue: 7.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	11	"T-reg: 53.3"	"Lineage enriched"	"Detected in single"	394	"T-cells: 53.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026301, HPA045943"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB026301: , HPA045943: AB_2679508"	"unprognostic (2.46e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (4.95e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (2.55e-4)"	"prognostic favorable (4.90e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.73e-14)"	"unprognostic (5.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-1)"	0.2	0.2	0.9	7.4	0.7	1.3	0.7	1.5	0.8	0.4	0.0	0.6	0.7	0.2	7.2	1.2	0.2	1.6	0.2	0.8	0.6	0.3	2.4	0.9	6.1	0.7	0.7	0.4	0.2	0.4	0.5	0.1	0.8	0.6	0.7	0.7	1.1	0.8	0.3	2.3	1.9	0.3	0.5	2.4	1.6	1.3	0.8	7.2	0.6	0.1	5.2	2.8	0.3	0.7	0.1	0.3	0.2	0.9	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.8	0.2	0.6	0.3	0.5	0.6	0.3	0.8	0.0	0.1	2.9	0.5	0.2	0.3	0.2	0.4	0.3	0.4	0.1	0.8	0.9	1.7	0.0	0.0	0.9	0.9	0.7	0.0	5.2	0.1	0.3	0.8	0.1	0.7	0.4	0.3	0.2	0.2	0.2	0.6	0.5	4.7	0.5	2.0	0.5	1.5	0.8	0.8	0.3	1.4	0.5	0.1	0.4	1.1	0.4	0.2	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	4.7	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	53.3	1.3	0.9	0.7	1.5	0.8	0.8	0.6	0.7	0.7	0.8	0.5	0.8	0.7	0.1	0.0	0.6	0.3	0.4	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.1	0.0	1.4	0.1	3.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.0	0.4	0.0	5.3	0.2	0.0	0.0
FTO	"ALKBH9, KIAA1752, MGC5149"	ENSG00000140718	"FTO alpha-ketoglutarate dependent dioxygenase"	Q9C0B1	16	53701692-54158512	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017123, HPA041086, HPA068695"	Enhanced		Supported	Vesicles,Cytosol		No	No		540000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Vesicles	"CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117"	"unprognostic (9.74e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.11e-3)"	24.4	33.6	31.8	12.5	36.6	8.2	36.3	30.1	37.7	25.8	31.0	22.2	7.7	26.9	21.4	17.2	25.3	21.6	27.1	35.2	39.5	25.0	17.4	36.8	15.0	29.2	31.3	27.2	20.7	40.6	26.2	20.1	31.9	20.0	14.1	38.4	18.9	23.9	33.1	21.4	12.5	29.9	30.5	16.4	15.0	8.3	33.8	17.0	27.5	23.0	14.8	21.9	18.5	43.9	15.1	26.8	35.0	35.9	67.3	50.4	11.5	35.6	32.2	29.3	8.5	16.8	19.3	34.4	38.2	46.3	16.6	21.7	32.4	34.9	42.5	16.0	25.5	15.5	33.6	31.7	46.2	12.5	17.1	55.9	36.5	26.6	32.5	36.6	44.1	25.1	15.2	8.4	48.1	11.8	28.0	19.2	18.1	15.5	17.5	42.2	52.9	32.3	44.6	12.3	43.0	29.7	40.4	23.6	10.8	33.7	31.1	29.3	42.4	36.4	23.9	19.8	22.1	15.9	13.9	35.0	33.9	22.9	28.7	14.9	17.9	9.7	25.6	22.7	32.4	17.6	24.4	25.9	23.8	17.4	22.5	24.4	2.9	26.4	16.5	9.5	26.6	23.1	31.8	36.6	30.1	37.7	35.2	39.5	29.2	31.3	31.9	30.5	33.8	43.9	15.1	80.1	62.0	173.3	10.3	12.4	10.0	8.6	13.6	22.8	69.1	39.5	22.3	15.7	54.4	7.3	12.5	9.3	10.2	4.8	7.9	9.0	39.1	11.0	18.3	17.4	6.6	9.7	226.1	5.7	7.4	23.1	9.7	9.9	25.9	16.8	11.0	13.8	9.2	16.8	240.7	6.6	10.2	9.0	13.2	69.9	14.3	11.8	10.6	134.0	5.5	19.6	10.3	210.6	282.5	5.5	5.0	15.1	18.7	6.0	4.5	15.8	182.7	14.1	13.1	21.6	16.8	3.5	3.4	11.0	9.1	5.1	12.9	17.8	6.3	7.9
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 12.6;choroid plexus: 7.4;heart muscle: 8.8;liver: 21.5;pituitary gland: 23.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.9	0.3	8.3	0.2	0.7	8.1	9.5	2.8	7.4	0.5	0.1	1.2	0.8	0.4	1.2	0.5	8.8	8.2	11.0	1.2	21.5	0.4	0.2	9.0	9.9	1.4	1.8	0.1	23.9	1.6	9.1	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	8.3	0.6	0.6	0.4	12.6	0.1	0.5	0.1	0.2	1.1	2.0	7.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.9	8.3	8.1	9.5	8.2	11.0	9.0	9.9	9.1	8.3	12.6	7.9	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 20.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	4.3	1.6	5.1	2.1	5.5	0.2	1.9	4.9	4.6	7.8	20.5	2.0	0.7	3.3	2.8	0.5	8.7	6.5	2.9	5.4	10.8	7.8	3.3	3.8	1.1	24.2	18.0	6.6	9.7	2.4	2.4	1.4	11.4	3.3	2.1	1.3	3.1	8.2	1.3	0.8	1.5	2.1	13.7	2.0	1.8	2.8	6.5	0.2	18.6	0.8	0.7	4.0	2.4	13.2	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	5.1	5.5	4.9	4.6	5.4	10.8	24.2	18.0	11.4	13.7	6.5	13.2	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 333.9;lymphoid tissue: 335.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	61.7	45.7	2.3	111.0	2.2	7.1	41.6	2.4	2.8	49.9	5.2	76.8	0.1	27.7	32.2	32.1	29.1	127.4	20.8	1.6	5.1	39.6	95.1	333.9	335.8	4.3	2.6	18.6	15.0	2.6	15.2	13.7	2.7	15.1	115.8	1.9	34.8	7.8	7.5	30.0	74.0	19.2	5.4	180.0	103.3	12.2	3.4	234.3	26.0	0.0	322.3	175.9	16.3	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	2.3	2.2	2.4	2.8	1.6	5.1	4.3	2.6	2.7	5.4	3.4	11.1	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741391-32747198	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.8;lymphoid tissue: 27.1"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 1196.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 41: Macrophages - Immune response"				"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	10.9	4.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	3.1	0.0	3.9	0.0	2.1	0.0	3.0	2.8	0.1	2.3	0.0	0.0	5.8	1.7	20.8	0.0	0.0	0.0	0.9	1.2	0.0	2.5	0.0	0.0	2.5	0.0	0.0	3.4	0.0	1.4	8.4	11.6	0.0	0.0	27.1	2.9	0.6	0.0	0.3	3.7	0.0	0.3	3.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	3.2	3.6	0.0	179.2	23.5	0.3	1.8	1.2	0.0	2.5	1.3	0.5	0.0	7.5	3.7	0.0	0.2	144.1	0.1	0.0	0.2	0.7	0.1	0.2	20.6	2.4	0.4	0.0	0.0	0.8	1.6	0.0	0.3	0.0	0.8	2.2	0.3	110.0	0.0	0.0	0.0	0.0	78.9	1196.5	2.0	1.2	243.1	24.9	0.0	125.3	0.0	8.2	0.0	0.0	0.2	0.0	0.0	9.5	0.0	0.0	11.2	12.4	0.0	6.6	0.7	1.2	0.1	0.3	0.1	23.3	0.4	13.8	0.0	0.0	0.7
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32578769-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 581.3;lymphoid tissue: 651.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.5"	"Immune cell enhanced"	"Detected in all"		"myeloid DC: 749.2"	"Group enriched"	"Detected in all"	9	"B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	311.4	162.1	7.2	220.8	7.8	61.3	239.4	6.4	47.5	121.4	11.1	113.5	2.4	90.3	140.6	71.7	119.4	66.9	134.6	6.2	11.4	217.5	100.6	581.3	651.4	6.8	7.1	40.4	50.8	0.0	80.2	13.6	6.9	88.4	135.3	5.2	93.8	0.4	58.3	122.5	353.2	11.1	9.9	516.2	232.3	25.5	9.2	254.3	129.5	0.0	257.4	116.2	91.5	13.4	0.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	17.1	0.0	0.0	1.9	0.0	4.7	0.0	1181.9	12.9	0.1	0.5	0.0	0.0	0.4	159.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	12.3	0.0	28.5	0.4	2.3	0.4	0.0	0.0	4.4	0.4	0.1	0.0	0.0	0.1	0.2	6.5	0.0	26.7	1.5	4.8	140.4	0.1	0.0	0.9	2.1	0.7	150.3	4.4	202.5	308.9	5.8	0.5	2.5	323.0	53.7	12.2	371.3	2.2	225.4	9.0	27.2	749.2	257.9	1.1	12.2	8.9	21.0	223.8	147.6	35.4	411.8	7.2	7.8	6.4	47.5	6.2	11.4	6.8	7.1	6.9	9.9	9.2	13.4	1241.9	147.4	609.1	0.0	2149.9	173.6	14.1	78.2	51.8	2.0	96.0	150.9	30.5	90.1	277.5	141.6	0.0	3.7	484.0	92.2	25.4	272.8	4.6	23.9	4.0	721.5	36.0	120.8	0.0	73.8	7.0	77.9	131.0	21.6	124.0	47.9	179.9	5.0	1417.7	0.0	0.0	92.7	30.5	1755.3	11630.1	12.3	14.9	3622.3	217.1	0.0	3104.1	7.7	55.6	0.0	0.0	89.1	308.9	26.7	120.2	21.0	1849.6	218.2	357.1	10.7	26.3	16.6	47.9	2.4	3.6	27.2	147.9	6.8	245.6	52.5	152.2	125.5
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.4;kidney: 16.7;liver: 34.7;pancreas: 9.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.0	5.5	15.4	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.7	34.7	0.0	0.0	0.1	0.1	0.0	9.5	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	14.3	0.1	0.0	0.0	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
IFIH1	"Hlcd, IDDM19, MDA-5, MDA5"	ENSG00000115267	"Interferon induced with helicase C domain 1"	Q9BYX4	2	162267074-162318684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.6;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 62.3;BJ hTERT+ SV40 Large T+ RasG12V: 71.5;Karpas-707: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002656	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA002656: AB_1079344"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.29e-2)"	6.2	6.4	3.1	12.7	4.3	38.1	5.9	3.2	3.0	6.5	4.4	7.4	13.1	6.4	4.3	7.5	7.2	9.5	5.1	2.3	3.3	5.6	8.5	10.9	11.7	7.2	3.4	7.0	7.1	8.1	5.9	8.3	5.0	5.5	6.8	1.1	17.5	4.7	1.7	5.0	10.0	5.7	8.1	16.4	9.6	2.4	4.2	10.9	6.0	3.2	9.7	6.4	5.2	4.4	6.7	0.3	0.2	0.0	7.4	6.0	2.8	1.2	17.7	62.3	71.5	1.2	16.7	13.3	10.5	1.0	31.9	8.5	1.1	9.8	6.3	35.4	4.5	7.1	0.8	2.8	5.0	8.2	6.4	5.3	4.8	8.9	1.7	6.5	4.9	6.9	0.3	38.9	1.0	12.5	9.3	6.4	0.0	5.4	3.8	7.5	0.0	18.8	5.9	7.3	0.4	0.1	3.7	20.7	34.0	0.3	5.7	7.1	4.1	1.9	1.7	1.1	2.7	15.2	26.8	1.9	3.5	6.5	5.6	4.4	11.5	4.4	6.6	12.5	9.2	12.4	8.2	7.2	11.1	12.8	6.7	6.9	15.2	4.0	12.7	1.6	10.3	7.8	3.1	4.3	3.2	3.0	2.3	3.3	7.2	3.4	5.0	8.1	4.2	4.4	24.7	32.1	12.0	4.6	20.1	6.8	11.2	7.7	6.2	0.0	4.8	5.2	5.0	12.8	11.1	7.3	0.0	6.4	10.2	10.9	5.9	18.7	55.6	17.3	7.9	22.3	15.7	8.2	2.8	18.7	17.5	8.8	10.7	20.2	13.3	10.4	13.6	6.5	14.4	0.0	0.7	11.5	8.2	12.8	8.7	53.3	13.7	20.0	5.4	28.1	23.9	7.3	10.3	0.5	4.0	13.4	10.1	13.2	16.0	9.1	11.8	4.8	17.5	0.1	0.0	10.9	4.9	1.6	1.3	10.2	5.8	3.4	13.1	6.9	6.7	11.1
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643130-185825042	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.6;Glandular and luminal cells: 117.7;Rod photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 263.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	8.0	9.0	0.9	4.1	1.1	11.9	5.3	6.4	2.0	7.2	1.3	12.6	15.0	5.0	0.7	3.3	11.2	7.5	9.0	1.0	2.1	8.2	1.6	11.7	1.3	2.2	2.1	6.6	4.9	6.4	1.4	15.1	1.3	1.9	14.9	22.3	9.3	1.1	2.0	4.4	16.0	4.6	1.5	4.4	13.2	6.1	1.9	2.2	7.3	3.4	1.8	3.8	5.5	1.2	129.4	11.0	124.2	22.5	64.8	102.5	73.2	68.5	94.2	102.2	121.6	94.1	36.2	0.0	98.2	56.9	130.1	57.7	58.4	97.3	163.9	0.2	58.2	37.7	0.6	64.1	140.2	1.2	0.2	75.0	50.4	67.6	263.9	53.2	95.3	10.1	37.6	0.1	75.2	1.1	0.3	27.8	87.3	22.1	45.7	13.5	48.1	38.8	63.7	0.4	7.7	1.2	5.0	0.2	113.5	120.5	10.1	82.1	144.8	34.8	74.8	44.6	78.2	0.4	0.2	0.3	34.7	0.1	50.3	0.4	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.7	1.7	0.4	0.0	0.6	0.9	1.1	6.4	2.0	1.0	2.1	2.2	2.1	1.3	1.5	1.9	1.2	6.2	12.8	11.6	2.3	0.6	19.8	20.1	48.1	1.2	5.2	18.4	6.2	15.7	44.3	49.2	25.8	16.7	2.8	0.9	82.0	3.9	38.9	126.6	86.4	13.8	18.9	35.6	46.9	0.7	25.4	18.0	25.3	20.9	117.7	2.5	64.5	39.7	0.5	16.4	1.7	1.1	44.7	46.8	8.8	16.9	81.7	5.3	10.5	14.2	13.1	11.3	21.2	6.2	4.5	0.2	61.1	80.1	0.4	1.5	63.0	68.8	11.4	74.8	176.7	0.0	2.0	18.8	4.7	14.4	1.2	14.6	6.3	1.1	0.8	45.9	77.8
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Melanocytes: 3.6;T-cells: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010310	Uncertain				"Secreted to blood"	NA	NA	20300					"Cluster 7: Non-specific - Mitochondria"			"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.4	0.0	0.0	0.0
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122610108-122621066	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"lymphoid tissue: 5.9"	"Group enriched"	"Detected in some"	18	"Early spermatids: 13.7;Late spermatids: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	55700			"Cluster 16: Immune cells - Immune response"		"Cluster 34: Spermatids - Unknown function"											"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;lymphoid tissue: 17.4;urinary bladder: 11.2"	"Group enriched"	"Detected in some"	6	"granulocytes: 80.8;monocytes: 177.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 175.9;T-reg: 248.0"	"Group enriched"	"Detected in many"	14	"granulocytes: 175.9;T-cells: 248.0"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 1113.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002419, HPA054622"	Enhanced					NA	NA		410000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	18.9	1.9	0.0	14.2	0.0	0.4	1.4	0.1	0.2	0.5	1.1	3.3	1.9	0.5	0.2	2.6	0.3	2.9	0.8	0.1	0.1	0.7	0.5	2.4	17.4	0.5	0.1	0.1	0.5	0.3	0.9	2.5	0.4	0.4	2.1	0.0	0.5	0.8	0.1	0.4	6.5	4.7	0.1	7.5	1.2	0.2	0.2	5.2	1.3	0.6	12.9	11.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1113.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	0.4	18.9	0.0	0.3	0.0	175.9	0.1	20.1	0.6	0.0	2.2	14.7	27.3	3.1	0.2	7.3	2.0	0.2	0.9	13.4	0.3	0.2	248.0	3.2	0.0	0.0	0.1	0.2	0.1	0.1	0.5	0.1	0.4	0.1	0.2	0.2	0.4	0.0	1.8	1.0	13.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.2	0.2	0.6	0.4	0.0	0.8	0.2	0.6	0.0	0.7	1.1	0.1	80.8	0.0	0.4	0.2	0.3	0.0	0.2	0.0	0.0	7.7	4.8	0.1	0.0	19.3	3.6	1.9	177.6	0.0	2.1	0.0	0.3	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.1	0.6	0.0	19.6	0.0	0.1	0.2
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161221	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"pancreas: 12983.6"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 1475.2"	"Cancer enriched"	"Detected in single"	7165	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"midbrain: 1.3"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000			"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							19.2	4.0	0.1	0.2	0.1	49.8	0.6	0.0	0.0	0.7	0.0	12.8	1.5	1.4	0.0	1.8	0.3	3.7	5.6	0.1	0.1	40.7	1.4	1.7	5.4	0.2	0.4	2.6	12983.6	0.0	0.3	1.4	0.8	0.5	0.0	0.0	3.1	0.0	0.3	96.4	0.7	0.0	0.0	1.4	42.2	0.3	0.0	0.0	1.3	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	268.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	376.2	0.0	31.8	0.0	15.9	132.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	67.2	0.0	0.0	0.0	0.0	1475.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 54.9;U-266/70: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	Yes		190000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.0	22.6	12.5	2.8	16.8	5.6	13.0	17.3	12.8	14.6	18.8	15.0	10.0	18.4	6.3	4.1	16.9	8.2	26.3	10.0	12.2	21.8	33.0	7.2	2.3	18.3	16.3	39.9	64.2	13.0	16.3	7.4	18.7	15.2	10.4	6.5	16.9	9.9	23.5	11.5	12.2	11.5	14.1	48.2	12.5	5.4	16.6	2.7	14.5	13.3	3.5	12.3	9.2	22.5	6.2	3.2	3.6	5.7	18.8	6.1	11.1	3.5	2.9	1.6	1.6	8.4	7.0	9.0	8.2	6.8	4.0	1.6	8.9	1.4	1.2	0.0	6.4	0.0	2.3	22.6	8.2	4.3	6.7	10.0	4.5	0.2	4.9	4.2	3.8	4.8	9.5	54.9	1.8	3.2	3.1	7.8	3.3	3.8	5.2	29.0	2.1	7.6	0.1	27.8	6.6	5.2	6.5	3.8	3.3	6.4	1.4	21.6	3.6	3.4	2.1	8.2	5.1	40.4	23.9	20.2	4.3	7.3	0.0	2.7	8.6	5.9	0.2	8.8	0.3	0.8	0.3	0.1	9.8	1.1	0.7	0.1	1.9	1.0	12.5	8.2	0.0	1.6	12.5	16.8	17.3	12.8	10.0	12.2	18.3	16.3	18.7	14.1	16.6	22.5	75.6	48.1	34.7	64.9	10.6	64.9	63.6	34.7	8.0	40.4	134.0	76.2	92.1	137.2	83.3	62.5	79.2	17.8	6.7	124.1	15.6	55.1	4.7	26.8	106.8	123.9	163.6	25.0	68.3	78.7	53.7	43.7	20.4	42.1	3.8	168.4	255.2	246.0	9.2	38.7	100.8	97.3	32.6	49.0	31.1	9.0	96.3	35.0	51.6	62.8	24.2	31.6	0.0	62.8	183.5	50.7	68.8	245.3	21.8	107.9	122.9	114.1	65.3	23.6	59.2	37.6	44.2	5.2	3.6	3.2	68.8	38.3	4.7	81.4	65.2	130.0
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 164.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	16.3	11.4	5.5	17.0	5.0	6.1	14.6	3.8	5.3	18.0	3.7	26.2	29.1	8.5	13.1	18.1	14.0	15.3	15.0	3.8	3.9	16.4	2.2	30.6	20.4	5.6	5.0	13.5	11.3	2.8	7.4	4.3	5.2	13.9	18.4	0.8	18.5	11.2	4.5	58.9	35.1	4.7	4.7	39.8	41.5	15.4	7.0	14.3	54.0	5.1	21.0	12.1	24.0	3.9	73.7	34.0	6.3	0.3	6.2	19.3	40.9	24.8	62.8	30.5	27.4	46.7	55.9	62.6	26.1	17.9	76.1	70.9	28.6	66.7	15.7	36.8	24.0	0.1	102.6	52.0	14.1	11.3	7.9	14.0	59.2	76.7	164.7	66.5	52.1	24.5	25.0	19.7	33.3	35.0	19.0	6.4	6.2	55.8	49.4	29.0	0.1	37.1	107.6	50.9	57.3	2.1	42.8	61.6	60.2	6.9	21.2	5.9	71.8	41.1	20.1	53.1	55.2	13.5	14.3	29.4	32.8	16.6	24.1	0.8	0.0	0.0	0.8	0.0	0.6	0.4	0.4	0.5	0.0	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.7	0.2	5.5	5.0	3.8	5.3	3.8	3.9	5.6	5.0	5.2	4.7	7.0	3.9	12.4	48.1	58.9	0.3	13.5	26.5	10.9	27.9	18.2	1.5	9.3	9.9	2.7	12.8	20.2	31.3	0.0	0.3	10.9	52.9	0.0	28.4	123.0	19.1	9.1	18.2	23.9	6.6	1.1	30.2	6.3	9.2	127.4	43.1	0.0	0.2	12.5	0.4	0.5	0.0	1.6	41.6	10.2	0.6	6.9	220.4	23.3	2.6	12.4	23.4	3.2	0.4	4.1	0.5	0.4	89.7	41.6	13.9	18.7	20.5	45.9	0.2	12.1	1.2	6.6	3.9	3.3	1.6	3.2	14.5	25.4	0.5	13.1	5.8	35.6	20.7
JAZF1	"DKFZp761K2222, TIP27, ZNF802"	ENSG00000153814	"JAZF zinc finger 1"	Q86VZ6	7	27830573-28180795	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Lipid metabolism, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 83.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 160.1;Excitatory neurons: 316.6;Inhibitory neurons: 306.3;Microglial cells: 168.6;Oligodendrocyte precursor cells: 241.3;Oligodendrocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 25.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.7;granulocytes: 25.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019271, HPA066967"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB019271: , HPA066967: AB_2685758"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-2)"	15.4	83.8	11.1	10.9	12.4	24.4	11.7	11.5	16.5	62.4	12.4	32.8	3.4	41.8	21.3	10.1	16.4	12.4	22.4	13.2	15.3	5.1	15.7	10.1	14.6	7.3	8.3	13.9	6.6	6.3	13.4	16.1	9.1	29.5	8.3	7.8	4.6	35.2	6.9	7.1	8.3	38.6	8.1	14.6	8.3	18.8	17.4	11.5	14.9	6.9	15.9	19.2	27.3	10.0	1.4	0.8	4.8	1.0	35.6	42.9	0.0	11.1	28.6	18.4	22.8	0.1	7.6	33.7	22.6	23.5	12.5	0.7	6.3	8.5	15.0	5.1	10.2	12.2	7.7	0.0	24.2	4.8	3.1	19.4	10.2	13.8	8.9	14.1	11.8	2.2	0.3	53.2	10.3	1.4	1.3	17.5	10.0	0.2	7.7	3.6	2.2	10.1	6.7	0.3	3.0	4.7	9.2	0.3	12.0	14.0	3.5	6.1	11.7	29.0	11.0	8.0	12.9	9.2	2.9	12.5	9.2	12.5	16.2	25.6	3.9	6.9	4.8	3.3	1.3	2.8	1.3	3.2	3.7	3.7	0.5	3.0	1.5	4.1	3.5	13.7	3.2	3.1	11.1	12.4	11.5	16.5	13.2	15.3	7.3	8.3	9.1	8.1	17.4	10.0	10.2	3.2	7.0	57.8	33.4	14.7	3.0	3.8	3.4	6.7	3.5	4.8	25.3	10.0	3.0	1.8	6.2	0.5	37.9	1.3	7.9	14.8	122.1	28.3	160.1	14.5	5.4	115.6	316.6	2.3	1.4	24.6	9.2	18.6	24.1	12.6	3.6	5.5	9.4	16.8	306.3	0.6	2.0	25.7	45.6	89.8	55.0	28.0	23.2	168.6	35.5	4.4	40.2	241.3	262.5	5.3	0.4	34.6	8.7	2.7	0.0	2.4	12.7	4.7	13.1	9.9	15.3	8.7	16.5	3.4	11.2	1.4	25.3	1.6	0.3	1.5
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium inwardly rectifying channel subfamily J member 11"	Q14654	11	17385248-17389331	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 134.7;tongue: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048891	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.7	0.6	5.1	0.4	8.3	0.2	3.0	12.4	11.9	0.6	0.0	1.1	1.0	0.9	1.6	1.5	0.7	0.5	13.8	5.3	4.2	4.7	1.5	2.5	0.8	8.0	3.4	0.3	11.3	5.0	7.4	0.1	8.2	2.2	0.4	1.3	2.2	2.4	134.7	1.5	1.3	0.1	2.6	1.6	13.1	0.6	6.4	0.3	5.1	40.7	0.5	0.9	0.4	5.9	1.5	2.1	0.2	4.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	2.0	0.2	6.6	0.2	0.0	0.3	0.3	4.1	0.1	0.2	1.6	12.3	3.4	0.9	0.5	0.1	0.5	0.3	0.1	0.2	0.0	0.1	0.1	0.0	5.6	3.5	3.6	0.0	10.0	0.7	0.1	1.1	4.0	0.3	1.3	1.6	2.0	0.3	0.9	8.5	0.7	0.0	3.4	0.0	0.0	4.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	6.5	0.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	8.3	12.4	11.9	5.3	4.2	8.0	3.4	8.2	2.6	6.4	5.9	1.5	0.0	2.7	3.3	0.1	0.0	0.1	0.0	0.0	2.1	2.6	0.9	14.1	0.0	0.6	5.5	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.3	0.3	4.2	0.0	5.5	0.4	0.0	0.9	0.0	0.6	0.0	0.2	0.4	1.3	0.1	0.0	5.9	0.9	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.0	0.8	0.1	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.7	0.0	1.3	0.2	0.2	0.3	1.0	0.0	0.0	0.0	0.1	0.4	0.2
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KLF11	"MODY7, TIEG2, Tieg3"	ENSG00000172059	"Kruppel like factor 11"	O14901	2	10042849-10054836	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.0;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058276			Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol"		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Focal adhesion sites, Cytosol"	"HPA058276: AB_2683664"	"unprognostic (9.66e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.63e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.24e-2)"	27.7	15.6	4.0	7.6	3.2	27.8	22.3	8.3	3.9	13.5	4.1	17.9	7.5	20.0	9.7	13.2	13.7	18.1	19.1	2.9	3.9	15.7	35.2	22.4	9.3	3.7	3.3	23.9	54.2	18.3	2.5	19.5	3.4	10.1	9.3	3.0	15.9	14.8	12.1	26.9	8.7	16.8	3.2	18.8	12.4	30.0	3.5	4.0	16.5	27.3	5.5	12.6	13.1	5.1	6.9	3.3	7.8	0.7	5.3	9.4	18.8	7.9	7.9	4.4	4.6	7.8	15.8	0.0	13.9	9.6	17.9	1.6	6.8	6.1	2.9	47.6	5.2	3.5	9.7	1.6	5.2	14.6	22.1	14.7	22.3	8.4	2.3	11.4	3.9	1.3	9.7	30.8	4.6	8.2	0.0	2.7	12.5	5.6	6.7	7.8	0.2	13.6	10.8	8.5	10.0	6.2	12.0	24.5	23.4	12.2	5.7	19.6	11.2	19.3	15.9	14.7	2.6	27.9	36.0	18.7	5.0	3.8	10.4	0.0	8.2	2.0	2.6	12.3	0.8	3.2	1.8	1.9	7.3	2.9	0.5	1.1	0.2	6.6	14.8	0.3	3.0	5.4	4.0	3.2	8.3	3.9	2.9	3.9	3.7	3.3	3.4	3.2	3.5	5.1	58.8	6.4	4.6	0.3	12.5	60.5	17.7	5.5	25.6	6.2	14.3	13.2	3.5	10.0	6.1	7.3	6.2	3.2	10.1	2.5	29.4	8.2	135.0	9.1	21.5	33.3	7.1	4.6	1.7	8.5	4.2	17.5	9.7	26.6	8.2	15.5	37.5	38.1	12.5	3.3	1.4	7.0	16.2	32.4	42.4	25.9	14.6	22.0	30.2	1.0	16.6	2.2	3.1	0.5	0.3	8.9	1.5	16.6	5.3	15.0	6.1	8.4	4.3	5.8	32.9	10.4	35.7	13.8	39.0	13.1	86.2	8.2	10.8	11.2	7.8	11.7
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969651-92985066	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.1;placenta: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"GAMG: 4.9;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA074024	Supported					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA074024: "					"unprognostic (3.61e-1)"												"unprognostic (1.43e-1)"	0.0	0.0	2.2	0.0	2.8	0.0	0.0	0.7	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	3.0	2.8	0.0	0.0	0.0	0.0	1.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.7	1.1	2.3	1.2	3.0	2.8	3.1	2.1	1.2	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NEUROD1	"BETA2, BHF-1, bHLHa3, MODY6, NEUROD"	ENSG00000162992	"Neuronal differentiation 1"	Q13562	2	181673088-181680547	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 61.4;retina: 125.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 77.5;Cone photoreceptor cells: 150.1;Enteroendocrine cells: 424.2;Rod photoreceptor cells: 203.7"	"Group enriched"	"Detected in some"	4	"glioma: 1.9;pancreatic cancer: 4.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 61.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	74	"SCLC-21H: 321.5"	"Region enriched"	"Detected in all"	14	"cerebellum: 216.2"	"Region enriched"	"Detected in many"	19	"cerebellum: 217.0"	"HPA003278, CAB022450"	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB022450: , HPA003278: AB_1845331"			"unprognostic (1.29e-1)"		"prognostic favorable (1.34e-4)"						"unprognostic (6.92e-3)"			"unprognostic (1.27e-1)"				0.0	0.1	3.0	0.1	2.1	0.1	0.0	61.4	7.2	0.0	0.7	1.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.7	0.0	0.0	0.0	0.0	0.9	2.4	0.0	10.2	0.0	0.7	0.0	5.2	0.0	1.4	125.7	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.4	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	321.5	4.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.1	3.0	2.1	61.4	7.2	9.2	0.7	0.9	2.4	5.2	0.9	0.8	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	77.5	0.0	0.0	0.5	0.0	0.0	0.0	150.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.9	424.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	23.8	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.1	1.7	12.6	0.0	0.0	0.2	0.7	0.1	0.0	203.7	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.2
NOTCH2		ENSG00000134250	"Notch receptor 2"	Q04721	1	119911553-120100779	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		160000000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	27.1	12.9	16.4	20.4	13.6	13.7	24.8	11.9	16.4	31.0	20.3	16.0	5.4	21.2	20.8	24.9	25.7	18.5	14.2	15.9	13.7	10.9	19.6	20.2	16.7	20.6	18.6	33.9	20.1	12.1	5.5	24.9	13.9	20.4	13.6	19.3	17.1	22.2	6.4	32.3	11.9	26.6	15.7	25.3	10.5	25.4	19.3	15.3	21.2	8.9	17.9	19.0	24.1	14.8	54.2	17.7	27.0	20.7	108.5	92.7	26.6	39.7	54.8	51.8	55.8	16.3	14.2	1.4	32.6	75.3	46.2	20.1	42.8	35.3	82.5	64.0	27.2	32.1	45.7	1.6	40.5	32.7	8.0	75.5	22.5	155.2	103.7	78.4	26.9	14.5	0.8	65.3	63.7	59.2	13.9	9.2	34.6	5.0	19.6	9.1	94.2	36.1	27.3	33.4	1.1	13.4	54.5	50.0	27.9	53.4	28.0	11.7	97.0	67.0	45.8	102.7	63.1	27.9	16.8	16.5	98.7	29.5	65.2	15.0	14.9	22.9	1.4	7.3	1.4	39.0	1.6	0.9	23.7	33.3	3.1	2.0	8.9	2.4	10.5	12.3	3.8	4.4	16.4	13.6	11.9	16.4	15.9	13.7	20.6	18.6	13.9	15.7	19.3	14.8	4.6	35.3	19.5	125.4	36.6	46.3	56.6	14.8	31.3	3.3	38.1	25.3	16.0	24.3	28.5	18.4	6.2	1.6	26.0	6.2	0.0	46.8	17.7	33.8	21.9	5.4	6.1	18.3	4.2	12.9	8.9	67.8	5.1	61.1	15.8	78.3	3.9	41.5	32.7	3.3	22.6	7.9	20.3	74.7	78.2	12.6	55.0	76.6	39.2	43.1	79.3	46.2	15.5	75.4	0.6	26.8	105.5	85.4	14.2	37.2	3.2	4.9	16.4	10.5	19.7	83.6	34.0	10.0	4.3	75.1	88.9	1.6	18.5	22.0	15.8	66.9
PAX4	MODY9	ENSG00000106331	"Paired box 4"	O43316	7	127610292-127618142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.0"	"Cell type enriched"	"Detected in some"	7	"Enteroendocrine cells: 85.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"						"unprognostic (1.52e-1)"								"unprognostic (9.71e-2)"			"unprognostic (4.86e-3)"	"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 165.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	165.1	3.9	4.0	8.7	3.0	3.0	74.3	3.2	4.7	9.7	0.6	48.7	23.6	7.0	1.2	6.2	7.0	10.5	14.6	4.0	2.7	14.3	17.1	28.5	4.9	3.7	3.5	14.5	2.8	7.9	0.5	43.6	3.4	5.5	40.6	1.0	5.7	1.7	5.2	6.2	15.1	8.7	3.2	12.0	35.5	6.9	3.5	4.1	13.2	8.1	2.1	67.7	9.1	5.0	44.0	38.6	0.0	0.2	198.7	113.7	247.5	3.7	44.7	5.4	2.1	7.8	111.6	0.0	0.1	4.0	72.9	17.3	14.4	0.7	1.0	106.4	20.3	0.0	8.1	10.3	51.8	0.2	0.1	118.9	9.7	9.8	37.5	20.6	0.7	1.0	0.0	0.0	8.3	11.0	0.1	0.8	0.7	99.2	112.0	0.0	0.0	0.2	30.6	157.5	0.1	1.2	18.8	6.7	2.2	6.7	0.0	34.2	35.0	7.8	10.6	4.6	0.2	0.0	0.1	0.3	3.2	0.5	1.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	3.0	3.2	4.7	4.0	2.7	3.7	3.5	3.4	3.2	3.5	5.0	284.1	3.2	7.2	1.6	0.6	1.0	50.5	0.4	4.6	0.9	1.9	2.8	9.2	1.5	2.5	5.5	0.0	110.4	1.8	93.4	1.9	1.1	4.9	5.2	1.4	26.1	8.4	0.0	39.3	0.7	217.8	12.3	83.1	20.8	8.9	232.9	25.7	3.4	49.9	0.0	74.1	21.3	0.0	19.4	4.8	2.2	4.1	19.1	3.6	38.4	1.8	0.6	0.0	6.6	1.2	17.3	84.1	0.0	1.6	42.1	17.0	14.3	1.5	0.2	13.1	1.9	31.3	10.9	22.8	4.6	1.1	88.9	2.2	0.8	24.5	239.6
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;dendritic cells: 22.4;NK-cells: 32.0;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 75.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.7"	"Cell line enhanced"	"Detected in many"		"HEL: 57.8;JURKAT: 40.0;MOLT-4: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.8	0.7	5.3	5.2	8.5	5.7	0.9	6.1	6.3	1.6	12.1	1.4	1.5	2.5	8.3	2.2	3.9	1.5	0.3	5.5	8.2	10.9	1.0	5.3	12.3	6.5	8.6	1.3	3.4	0.7	0.8	0.2	6.4	1.8	1.7	1.5	1.4	1.1	124.5	0.3	3.3	0.7	5.5	5.0	2.1	1.1	7.2	33.6	14.9	112.6	9.4	2.2	0.6	9.8	0.1	5.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.2	0.4	3.4	0.3	0.0	0.0	0.0	0.0	3.3	6.0	0.0	0.0	3.9	57.8	0.0	0.4	0.7	2.8	0.6	0.3	3.5	0.1	0.2	0.0	0.5	40.0	12.8	0.1	0.0	0.0	43.9	8.0	5.8	0.5	0.0	8.5	1.3	0.0	11.6	2.9	0.4	2.1	0.0	0.0	0.0	3.4	0.0	5.8	0.0	0.0	5.6	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	2.4	0.1	0.3	23.0	0.4	18.0	0.1	24.5	24.5	0.2	0.0	19.1	17.9	1.6	13.3	0.0	0.0	39.7	10.5	5.3	8.5	6.1	6.3	5.5	8.2	6.5	8.6	6.4	5.5	7.2	9.8	0.2	3.2	7.0	22.9	0.8	0.0	0.3	0.3	0.6	1.6	0.3	0.3	0.4	0.0	0.7	1.8	0.0	0.0	22.4	0.0	7.9	0.3	2.1	0.5	1.2	0.2	1.8	8.0	13.7	0.8	0.1	0.7	1.5	3.0	1.3	8.2	1.1	0.0	0.5	0.0	14.7	0.5	0.0	1.3	0.5	5.6	0.0	1.7	0.0	7.5	0.8	1.2	32.0	24.6	75.2	0.1	0.1	0.0	10.2	0.2	0.0	0.3	0.9	0.4	0.0	4.2	0.4	1.0	2.2	0.5	0.0	0.0	31.7	0.3	0.4	0.1
PTF1A	"bHLHa29, p48, PTF1-p48"	ENSG00000168267	"Pancreas associated transcription factor 1a"	Q7RTS3	10	23192312-23194245	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"pancreas: 104.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.1;Exocrine glandular cells: 4.8;Spermatocytes: 3.8"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.6;pancreatic cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022612			Approved	Nucleoplasm		NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB022612: "										"unprognostic (2.02e-1)"	"unprognostic (1.85e-1)"			"unprognostic (4.49e-1)"	"unprognostic (1.80e-1)"			0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.6	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.8	0.6	0.1	104.2	0.0	0.2	0.0	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.9	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	1.4	0.6	0.4	0.8	0.6	0.8	0.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932161	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.5;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5"	"Cell type enriched"	"Detected in some"	14	"Enteroendocrine cells: 68.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.4	0.0
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405923-111451623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	22.2	10.9	10.2	21.9	6.8	60.7	13.3	3.5	9.3	8.6	8.5	11.4	8.1	8.5	3.3	7.7	8.1	18.6	23.4	5.8	6.5	14.3	17.4	20.5	21.0	12.0	7.3	5.5	10.2	5.8	8.0	24.4	10.0	7.3	13.5	3.7	5.3	5.9	9.6	4.1	12.5	13.6	10.1	37.1	7.1	9.5	12.1	10.5	11.1	9.5	15.8	15.7	6.0	14.7	9.2	5.5	7.0	7.3	23.9	35.5	4.8	29.2	79.5	21.9	23.3	8.4	5.2	15.6	20.3	44.6	73.6	1.7	5.5	16.9	35.2	13.3	2.7	53.2	2.6	6.2	23.3	23.5	122.2	21.2	3.8	140.7	12.7	48.4	119.1	12.8	38.9	6.1	80.2	3.2	9.7	46.7	11.0	2.4	21.0	9.5	15.9	10.2	10.5	3.7	4.6	4.9	5.4	0.6	42.2	6.2	3.5	33.4	93.0	20.0	11.3	17.4	48.1	13.9	15.8	17.6	211.6	16.6	165.3	0.9	3.5	1.2	1.2	8.4	1.0	1.5	1.1	1.3	4.8	0.5	0.7	1.0	3.0	1.8	6.6	4.9	0.4	1.8	10.2	6.8	3.5	9.3	5.8	6.5	12.0	7.3	10.0	10.1	12.1	14.7	26.8	3.2	22.0	2.6	26.2	6.8	1.5	4.2	1.2	4.6	4.3	3.8	17.5	4.3	4.3	1.8	2.1	0.4	40.6	15.0	1.9	3.6	13.1	1.0	2.2	39.2	3.5	11.2	11.0	9.0	1.4	8.1	0.5	1.2	38.6	0.8	46.1	11.1	40.4	3.3	7.3	3.0	6.1	113.6	130.9	5.3	2.8	84.1	16.0	38.4	67.1	1.1	18.6	11.1	9.0	7.2	5.9	4.1	4.9	3.0	0.8	1.5	3.5	3.4	0.0	4.0	12.7	12.5	4.5	0.7	4.1	1.0	12.1	4.4	3.2	1.2
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 61.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"U-266/70: 48.0;U-266/84: 36.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 4.1"	HPA076165	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.2	0.2	0.1	0.0	0.3	0.6	0.7	0.0	0.2	0.1	0.2	0.2	0.3	0.2	4.3	0.0	0.1	0.1	0.2	0.1	0.0	61.8	0.3	0.3	0.3	0.3	0.1	0.2	0.2	12.9	0.0	0.0	0.8	1.0	0.2	0.0	0.0	1.1	2.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	48.0	36.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.2	0.3	0.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
TCF7L2	"TCF-4, TCF4"	ENSG00000148737	"Transcription factor 7 like 2"	Q9NQB0	10	112950247-113167678	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"brain: 244.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 244.9"	"Group enriched"	"Detected in many"	10	"intermediate monocyte: 28.9;non-classical monocyte: 86.6"	"Lineage enriched"	"Detected in many"	14	"monocytes: 86.6"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"midbrain: 67.2;thalamus: 86.6"	"Group enriched"	"Detected in all"	5	"midbrain: 146.8;pons: 97.8;thalamus: 164.3"	"CAB013535, HPA038800"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB013535: AB_2533167, HPA038800: "	"unprognostic (1.79e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.36e-3)"	28.1	9.4	47.4	8.6	6.3	7.6	25.0	0.2	12.1	18.9	1.0	22.9	20.4	25.1	6.7	9.9	18.1	9.4	11.3	4.3	46.9	9.9	22.4	13.9	5.4	5.1	98.0	22.9	12.4	11.1	9.6	17.7	1.7	12.3	21.3	4.6	14.5	13.1	8.4	17.2	19.3	16.4	1.6	22.2	23.3	7.6	244.9	5.8	12.9	6.9	3.7	13.8	14.3	3.2	15.0	37.8	40.7	39.6	20.8	13.7	48.5	10.3	20.0	7.1	8.5	24.9	45.3	0.1	11.3	19.4	9.6	10.5	14.0	17.6	9.1	1.7	13.1	10.4	25.2	23.6	22.0	4.2	3.7	24.4	6.3	11.0	18.2	29.7	12.0	8.8	11.0	0.7	8.2	28.0	6.7	2.5	29.2	16.6	21.6	19.0	29.8	6.9	15.2	20.4	0.8	12.4	15.7	15.4	17.0	31.5	10.0	2.2	27.9	6.8	18.7	16.9	21.3	2.6	0.3	0.4	6.5	8.7	14.9	0.4	4.5	0.4	1.5	28.9	0.9	0.0	0.4	1.2	4.1	0.0	0.4	0.6	6.0	0.0	86.6	0.2	0.0	3.5	47.4	6.3	0.2	12.1	4.3	46.9	5.1	98.0	1.7	1.6	244.9	3.2	62.0	22.4	26.5	264.8	3.3	42.6	27.3	35.8	64.9	2.8	53.0	54.9	13.6	52.9	35.5	40.5	6.2	44.2	9.1	260.0	11.7	39.3	8.8	40.1	140.6	46.1	19.8	4.8	35.1	43.6	231.4	90.8	90.2	64.2	0.0	37.6	52.8	74.2	17.5	5.0	16.6	87.7	16.2	99.9	20.6	5.0	59.0	54.6	32.0	107.7	22.4	34.4	5.2	192.5	34.9	59.0	211.1	48.5	6.0	38.4	75.3	16.2	26.8	6.1	92.1	37.3	51.3	9.4	28.9	61.1	39.8	28.5	6.7	13.1	73.9	49.0
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672483-29681155	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 8.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.8;Erythroid cells: 4.6;Extravillous trophoblasts: 4.4;Ionocytes: 8.2;Late spermatids: 5.9;Pancreatic endocrine cells: 4.0;Spermatogonia: 3.6"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.1"	"Group enriched"	"Detected in some"	13	"BEWO: 40.3;SuSa: 12.8"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.3	0.3	0.2	0.0	0.3	1.8	1.6	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.2	8.9	0.0	0.0	0.2	0.0	0.6	0.9	0.5	0.2	0.0	0.0	0.0	0.1	1.4	0.3	0.5	0.2	0.0	0.7	2.1	0.0	0.8	0.4	0.2	0.2	1.0	0.0	0.7	0.2	0.3	0.1	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.1	1.4	0.0	1.7	0.9	0.7	0.8	1.0	1.1	2.1	0.2	0.3	1.0	0.0	1.3	0.3	0.1	1.5	1.2	0.2	0.3	0.2	0.3	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.8	1.1	0.0	0.6	0.0	0.7	0.3	0.2	0.4	2.8	0.0	0.6	1.8	4.8	0.0	0.2	0.0	0.0	0.2	0.7	0.0	0.0	0.9	2.1	0.0	0.0	0.1	0.0	4.6	0.0	1.1	4.4	0.6	1.1	0.0	2.5	2.0	0.0	0.0	1.2	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	2.1	4.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	3.6	0.3	0.1	0.3	1.7	0.2	0.1	0.1